Recombinant FCRL5 (Cevostamab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA, FACS
Host: Humanized
Monoclonal
unconjugated
Recombinant Antibody
1 image
-
- Target
- FCRL5 (Cevostamab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
- Host
-
Humanized
- Clonality
- Monoclonal
- Application
- ELISA, Flow Cytometry (FACS)
- Purpose
- Anti-FCRL5 (cevostamab biosimilar without anti-CD3 portion) mAb
- Characteristics
- BFCR-4350-A, BFCR-4350A, RG-6160, RO-7187797
- Purification
- Purified from cell culture supernatant by affinity chromatography
- Grade
- Research Grade
- Isotype
- IgG1
-
- Application Notes
- ELISA 1:5000-10000, Flow Cyt 1:100
- Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Expiry Date
- 12 months
-
- Target
- FCRL5 (Cevostamab Biosimilar)
- Target Type
- Biosimilar
- Background
- Synonyms: BXMAS1, CD307, CD307e, FCRH5, IRTA2, PRO820
- UniProt
- Q96RD9
-
You are here:
